CervoMed (CRVO) Accumulated Depreciation (2013 - 2020)
CervoMed (CRVO) posted Accumulated Depreciation of $614601.0 for Q4 2020, up 20.17% sequentially from $511433.0 in Q4 2019, and up 20.17% YoY from $511433.0 in Q1 2020.
CervoMed (CRVO) Accumulated Depreciation (2013 - 2020) Analysis & Trends
CervoMed has reported Accumulated Depreciation for 8 years, with the latest figure at $614601.0 in Q4 2020.
- Quarterly Accumulated Depreciation rose 20.17% year-over-year to $614601.0 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $614601.0 (up 20.17% YoY) and the FY2020 annual result came in at $614601.0, up 20.17% from the prior year.
- Accumulated Depreciation rose to $614601.0 in Q4 2020 per CRVO's latest filing, from $511433.0 in the prior quarter.
- Over five years, Accumulated Depreciation peaked at $614601.0 in Q4 2020 and troughed at $239892.0 in Q4 2016.
- A 5-year average of $417986.6 and a median of $417189.0 in 2018 frame the typical range for Accumulated Depreciation.
- The sharpest annual moves came in 2016 and 2018: Accumulated Depreciation grew 11.56% in 2016, then surged 35.97% in 2018.
- Over 5 years, Accumulated Depreciation stood at $239892.0 in 2016, then grew by 27.9% to $306818.0 in 2017, then soared by 35.97% to $417189.0 in 2018, then grew by 22.59% to $511433.0 in 2019, then climbed by 20.17% to $614601.0 in 2020.
- According to Business Quant data, Accumulated Depreciation over the past three periods registered $614601.0, $511433.0, and $417189.0 for Q4 2020, Q4 2019, and Q4 2018 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | CervoMed | 26.64 Mn | 26.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 614,601.00 |
| Dec 31, 2019 | 511,433.00 |
| Dec 31, 2018 | 417,189.00 |
| Dec 31, 2017 | 306,818.00 |
| Dec 31, 2016 | 239,892.00 |
| Dec 31, 2015 | 215,029.00 |
| Sep 30, 2015 | 15,750.00 |
| Jun 30, 2015 | 10,356.00 |
| Dec 31, 2014 | 6,719.00 |
| Dec 31, 2013 | 212,816.00 |